ReportGem ReportGem 中文

GLOBAL RESEARCH ARCHIVE

Reminder: Expert Access – Event: Barclays Hosted Events at ADA 2026: Our Initial Schedule of Meetings and Expert Events

Published: 2026-05-26Institution: BarclaysPages: 6Original language: 英语Evidence page: 2

Research evidence excerpt

Reminder: Expert Access – Event: Barclays Hosted Events at ADA 2026: Our Initial Schedule of Meetings and Expert Events

Drinda Benjamin, VP Marketing

Modular Medical, Inc. (MODD) Group Meeting @ 9:15AM - 10:00AM CT

Management Attending:

Paul DiPerna, President and Founder

Laxmi Therapeutic Devices (PRIVATE) Group Meeting @ 2:45PM - 3:00PM CT

Peter Rule, Chief Executive Officer

Tom Metzmaker, VP, R&D

Monday, June 8th

KOL Breakfast - Obesity Breakfast Hosted by Emily Field & James Gordon

8:00AM - 9:00AM CT

Stocks in Focus: AZN, AMGN, LLY, NVO, PFE, ROP & ZEAL

KOL Speaker: Vivian A. Fonseca, MD

*More events in the coming days to be announced*

KOL Speaker Bio:

Vivian A. Fonseca, MD, FRCP, is a Professor of Medicine, Assistant Dean for Clinical

Research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of

Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He is a Past

President for the Science and Medicine of the American Diabetes Association (2012), and

has served on the ADA Board of Directors and several committees. He has served on the

Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the

Board of Trustees of the American College of Endocrinology. He has served on committees

writing guidelines for both organizations, and has held a leadership role, and served on

various committees in several other organizations including the American Board of

Internal Medicine. Dr. Fonseca has served on and been chairman of the clinical practice

committee of the American Diabetes Association, the ADA Disaster Task Force, ADA

strategic planning committee. He has played a significant role in developing guidelines for

treating diabetes (ADA and AACE). He is the Medical Director of the Tulane Clinical Trials

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer